[Letter: Refractory sideroblastic anemia and malignant hemopathies].
D000230:Adenocarcinoma / Q000150:complications; D000368:Aged; D000756:Anemia, Sideroblastic / Q000209:etiology*; D002430:Cecal Neoplasms / Q000150:complications; D005260:Female; D006801:Humans; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy; D011867:Radioisotope Teletherapy; D013125:Spinal Neoplasms / Q000150:complications* / Q000188:drug therapy; D013920:Thrombocythemia, Essential / Q000150:complications*
D008558:Melphalan
Anémies réfractaires sidéroblastiques et hémopathies malignes